Bruker Corporation (BRKR)
After hours:
- Business Wire
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
BILLERICA, Mass., May 07, 2024--Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the "928 Patent") in Germany (case 3 Ni 20/22). NanoString is now a Bruker business following Bruker’s asset acquisition of the businesses of NanoString Technologies, Inc on May 6th, 2024. The 928 Patent has been asserted by 10x Genomics against NanoString in patent infringe
- Simply Wall St.
Bruker First Quarter 2024 Earnings: Misses Expectations
Bruker ( NASDAQ:BRKR ) First Quarter 2024 Results Key Financial Results Revenue: US$721.7m (up 5.3% from 1Q 2023). Net...
- Business Wire
Bruker Completes Asset Acquisition of NanoString Business
BILLERICA, Mass., May 06, 2024--Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis.
